Journal of Virology

Total Page:16

File Type:pdf, Size:1020Kb

Journal of Virology JOURNAL OF VIROLOGY Volume 82 June 2008 No. 11 SPOTLIGHT Articles of Significant Interest Selected from This Issue by 5117 the Editors STRUCTURE AND ASSEMBLY Surface Loop Dynamics in Adeno-Associated Virus Capsid Nina DiPrimio, Aravind Asokan, 5178–5189 Assembly Lakshmanan Govindasamy, Mavis Agbandje-McKenna, and R. Jude Samulski Arrangement of L2 within the Papillomavirus Capsid Christopher B. Buck, Naiqian 5190–5197 Cheng, Cynthia D. Thompson, Douglas R. Lowy, Alasdair C. Steven, John T. Schiller, and Benes L. Trus Simultaneous Tracking of Capsid, Tegument, and Envelope Ken Sugimoto, Masashi Uema, 5198–5211 Protein Localization in Living Cells Infected with Triply Hiroshi Sagara, Michiko Tanaka, Fluorescent Herpes Simplex Virus 1 Tetsutaro Sata, Yasuhiro Hashimoto, and Yasushi Kawaguchi Proteomics Analysis Unravels the Functional Repertoire of Benjamin W. Neuman, Jeremiah S. 5279–5294 Coronavirus Nonstructural Protein 3 Joseph, Kumar S. Saikatendu, Pedro Serrano, Amarnath Chatterjee, Margaret A. Johnson, Lujian Liao, Joseph P. Klaus, John R. Yates III, Kurt Wu¨thrich, Raymond C. Stevens, Michael J. Buchmeier, and Peter Kuhn Structural Basis for the Receptor Binding Specificity of Weiming Bu, Aygun Mamedova, 5340–5347 Norwalk Virus Ming Tan, Ming Xia, Xi Jiang, and Rashmi S. Hegde Proteomic Analysis of Pathogenic and Attenuated Inga Dry, David M. Haig, Neil F. 5390–5397 Alcelaphine Herpesvirus 1 Inglis, Lisa Imrie, James P. Stewart, and George C. Russell Plasma Membrane Microdomains Containing Vesicular B. Dancho Swinteck and Douglas 5536–5547 Stomatitis Virus M Protein Are Separate from S. Lyles Microdomains Containing G Protein and Nucleocapsids GENOME REPLICATION AND REGULATION OF VIRAL GENE EXPRESSION Inhibition of Transcription and DNA Replication by the Ingo Ammermann, Markus 5127–5136 Papillomavirus E8ˆE2C Protein Is Mediated by Interaction Bruckner, Frank Matthes, Thomas with Corepressor Molecules Iftner, and Frank Stubenrauch Identification of a Highly Conserved, Functional Nuclear F. Abaitua and P. O’Hare 5234–5244 Localization Signal within the N-Terminal Region of Herpes Simplex Virus Type 1 VP1-2 Tegument Protein Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Feng Yang, Jason M. Robotham, 5269–5278 Infection and the Principal Mediator of Cyclosporine Heather B. Nelson, Andre Irsigler, Resistance In Vitro Rachael Kenworthy, and Hengli Tang Continued on following page Continued from preceding page Ataxia Telangiectasia-Mutated Damage-Signaling Kinase- Xiaorong Zhao, Ramiro J. Madden- 5316–5328 and Proteasome-Dependent Destruction of Mre11-Rad50- Fuentes, Becky X. Lou, James M. Nbs1 Subunits in Simian Virus 40-Infected Primate Cells Pipas, Jeannine Gerhardt, Christopher J. Rigell, and Ellen Fanning Nuclear Localization Sequences in Cytomegalovirus Capsid Nang L. Nguyen, Amy N. Loveland, 5381–5389 Assembly Proteins (UL80 Proteins) Are Required for Virus and Wade Gibson Production: Inactivating NLS1, NLS2, or Both Affects Replication to Strikingly Different Extents Paucity of CD4؉ CCR5؉ T Cells May Prevent Transmission Ivona Pandrea, Richard Onanga, 5501–5509 of Simian Immunodeficiency Virus in Natural Nonhuman Sandrine Souquiere, Augustin Primate Hosts by Breast-Feeding Mouinga-Onde´me, Olivier Bourry, Maria Makuwa, Pierre Rouquet, Guido Silvestri, Franc¸ois Simon, Pierre Roques, and Cristian Apetrei Roles of LEF-4 and PTP/BVP RNA Triphosphatases in Yi Li and Linda A. Guarino 5573–5583 Processing of Baculovirus Late mRNAs Comparison of Cellular Ribonucleoprotein Complexes Sarah Gallois-Montbrun, Rebecca 5636–5642 Associated with the APOBEC3F and APOBEC3G Antiviral K. Holmes, Chad M. Swanson, Proteins Mireia Ferna´ndez-Ocan˜a, Helen L. Byers, Malcolm A. Ward, and Michael H. Malim GENETIC DIVERSITY AND EVOLUTION Microevolution of Dengue Viruses Circulating among Richard G. Jarman, Edward C. 5494–5500 Primary School Children in Kamphaeng Phet, Thailand Holmes, Prinyada Rodpradit, Chonticha Klungthong, Robert V. Gibbons, Ananda Nisalak, Alan L. Rothman, Daniel H. Libraty, Francis A. Ennis, Mammen P. Mammen, Jr., and Timothy P. Endy New Complex Recombinant Genotype of Hepatitis B Virus Tran Thien Tuan Huy, Trinh Thi 5657–5663 Identified in Vietnam Ngoc, and Kenji Abe VIRUS-CELL INTERACTIONS Importance of the Membrane-Perturbing Properties of the Sundaram A. Vishwanathan and 5118–5126 Membrane-Proximal External Region of Human Eric Hunter Immunodeficiency Virus Type 1 gp41 to Viral Fusion Persistent Replication of Severe Acute Respiratory Filippo Pacciarini, Silvia Ghezzi, 5137–5144 Syndrome Coronavirus in Human Tubular Kidney Cells Filippo Canducci, Amy Sims, Selects for Adaptive Mutations in the Membrane Protein Michela Sampaolo, Elena Ferioli, Massimo Clementi, Guido Poli, Pier Giulio Conaldi, Ralph Baric, and Elisa Vicenzi Vaccinia Virus A56/K2 Fusion Regulatory Protein Interacts Timothy R. Wagenaar, Suany 5153–5160 with the A16 and G9 Subunits of the Entry Fusion Complex Ojeda, and Bernard Moss Structural and Genetic Requirements for the Biogenesis of Livia Donaire, Daniel Barajas, 5167–5177 Tobacco Rattle Virus-Derived Small Interfering RNAs Bele´n Martı´nez-Garcı´a, Llucia Martı´nez-Priego, Israel Paga´n, and Ce´sar Llave West Nile Virus Entry Requires Cholesterol-Rich Membrane Guruprasad R. Medigeshi, Alec J. 5212–5219 Microdomains and Is Independent of ␣v␤3 Integrin Hirsch, Daniel N. Streblow, Janko Nikolich-Zugich, and Jay A. Nelson Herpes Simplex Virus Type 2 UL56 Interacts with the Yoko Ushijima, Tetsuo Koshizuka, 5220–5233 Ubiquitin Ligase Nedd4 and Increases Its Ubiquitination Fumi Goshima, Hiroshi Kimura, and Yukihiro Nishiyama Continued on following page Continued from preceding page MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Qinyan Yin, Jane McBride, Claire 5295–5306 Modulates Epstein-Barr Virus-Regulated Gene Expression Fewell, Michelle Lacey, Xia Wang, Pathways Zhen Lin, Jennifer Cameron, and Erik K. Flemington Endoplasmic Reticulum Chaperones Are Involved in the Liliana Maruri-Avidal, Susana 5368–5380 Morphogenesis of Rotavirus Infectious Particles Lo´pez, and Carlos F. Arias Role of the Membrane-Spanning Domain of Human Liang Shang, Ling Yue, and Eric 5417–5428 Immunodeficiency Virus Type 1 Envelope Glycoprotein in Hunter Cell-Cell Fusion and Virus Infection Upregulation of the TLR3 Pathway by Kaposi’s Sarcoma- John West and Blossom Damania 5440–5449 Associated Herpesvirus during Primary Infection An Alteration of Human Immunodeficiency Virus gp41 Brian M. Taylor, J. Scott Foulke, 5460–5471 Leads to Reduced CCR5 Dependence and CD4 Robin Flinko, Alonso Heredia, Independence Anthony DeVico, and Marvin Reitz Epstein-Barr Virus Latent Membrane Protein 1 Induces Che-Pei Kung and Nancy Raab- 5486–5493 Expression of the Epidermal Growth Factor Receptor Traub through Effects on Bcl-3 and STAT3 Herpes Simplex Virus Virion Host Shutoff Attenuates Tracy Jo Pasieka, Betty Lu, Seth D. 5527–5535 Establishment of the Antiviral State Crosby, Kristine M. Wylie, Lynda A. Morrison, Diane E. Alexander, Vineet D. Menachery, and David A. Leib Coreceptor Tropism Can Be Influenced by Amino Acid Wei Huang, Jonathan Toma, Signe 5584–5593 Substitutions in the gp41 Transmembrane Subunit of Fransen, Eric Stawiski, Jacqueline Human Immunodeficiency Virus Type 1 Envelope Protein D. Reeves, Jeannette M. Whitcomb, Neil Parkin, and Christos J. Petropoulos CELLULAR RESPONSE TO INFECTION Restriction of Foamy Viruses by Primate Trim5␣ Melvyn W. Yap, Dirk Lindemann, 5429–5439 Nicole Stanke, Juliane Reh, Dana Westphal, Helmut Hanenberg, Sadayuki Ohkura, and Jonathan P. Stoye TRANSFORMATION AND ONCOGENESIS Mutations Affecting the MA Portion of the v-Abl Protein Chae-ryun Yi and Naomi Rosenberg 5307–5315 Reveal a Conserved Role of Gag in Abelson Murine Leukemia Virus (MLV) and Moloney MLV VACCINES AND ANTIVIRAL AGENTS A Direct Comparison of Human Papillomavirus Type 16 L1 Nadja Tho¨nes, Anna Herreiner, 5472–5485 Particles Reveals a Lower Immunogenicity of Capsomeres Lysann Scha¨dlich, Konrad Piuko, than Viruslike Particles with Respect to the Induced and Martin Mu¨ller Antibody Response Persistence of Transmitted Drug Resistance among Subjects Susan J. Little, Simon D. W. Frost, 5510–5518 with Primary Human Immunodeficiency Virus Infection Joseph K. Wong, Davey M. Smith, Sergei L. Kosakovsky Pond, Caroline C. Ignacio, Neil T. Parkin, Christos J. Petropoulos, and Douglas D. Richman Recruitment of Antigen-Presenting Cells to the Site of Jinyan Liu, Rune Kjeken, Iacob 5643–5649 Inoculation and Augmentation of Human Immunodeficiency Mathiesen, and Dan H. Barouch Virus Type 1 DNA Vaccine Immunogenicity by In Vivo Electroporation Continued on following page Continued from preceding page Recombinant Vesicular Stomatitis Virus Vector Mediates Thomas W. Geisbert, Kathleen M. 5664–5668 Postexposure Protection against Sudan Ebola Hemorrhagic Daddario-DiCaprio, Kinola J. N. Fever in Nonhuman Primates Williams, Joan B. Geisbert, Anders Leung, Friederike Feldmann, Lisa E. Hensley, Heinz Feldmann, and Steven M. Jones PATHOGENESIS AND IMMUNITY Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Ousmane M. Diop, Mickae¨l J.-Y. 5145–5152 Production during Simian Immunodeficiency Virus Infection Ploquin, Lorenzo Mortara, with a Nonpathogenic Outcome Abdourahmane Faye, Be´atrice Jacquelin, De´sire´e Kunkel, Pierre Lebon, Ce´cile Butor, Anne Hosmalin, Franc¸oise Barre´-Sinoussi, and Michaela C. Mu¨ller-Trutwin Cross-Recognition of Avian H5N1 Influenza Virus by J. H. C. M. Kreijtz, G. de Mutsert, 5161–5166 Human Cytotoxic T-Lymphocyte
Recommended publications
  • Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: a Review
    viruses Review Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review Dong Joo Seo 1 and Changsun Choi 2,* 1 Department of Food Science and Nutrition, College of Health and Welfare and Education, Gwangju University 277 Hyodeok-ro, Nam-gu, Gwangju 61743, Korea; [email protected] 2 Department of Food and Nutrition, School of Food Science and Technology, College of Biotechnology and Natural Resources, Chung-Ang University, 4726 Seodongdaero, Daeduck-myun, Anseong-si, Gyeonggi-do 17546, Korea * Correspondence: [email protected]; Tel.: +82-31-670-4589; Fax: +82-31-676-8741 Abstract: Mushrooms are used in their natural form as a food supplement and food additive. In addition, several bioactive compounds beneficial for human health have been derived from mushrooms. Among them, polysaccharides, carbohydrate-binding protein, peptides, proteins, enzymes, polyphenols, triterpenes, triterpenoids, and several other compounds exert antiviral activity against DNA and RNA viruses. Their antiviral targets were mostly virus entry, viral genome replication, viral proteins, and cellular proteins and influenced immune modulation, which was evaluated through pre-, simultaneous-, co-, and post-treatment in vitro and in vivo studies. In particular, they treated and relieved the viral diseases caused by herpes simplex virus, influenza virus, and human immunodeficiency virus (HIV). Some mushroom compounds that act against HIV, influenza A virus, and hepatitis C virus showed antiviral effects comparable to those of antiviral drugs. Therefore, bioactive compounds from mushrooms could be candidates for treating viral infections. Citation: Seo, D.J.; Choi, C. Antiviral Bioactive Compounds of Mushrooms Keywords: mushroom; bioactive compound; virus; infection; antiviral mechanism and Their Antiviral Mechanisms: A Review.
    [Show full text]
  • Norovirus Infectious Agent Information Sheet
    Norovirus Infectious Agent Information Sheet Introduction Noroviruses are non-enveloped (naked) RNA viruses with icosahedral nucleocapsid symmetry. The norovirus genome consists of (+) ssRNA, containing three open reading frames that encode for proteins required for transcription, replication, and assembly. There are five norovirus genogroups (GI-GV), and only GI, GII, and GIV infect humans. Norovirus belongs to the Caliciviridae family of viruses, and has had past names including, Norwalk virus and “winter-vomiting” disease. Epidemiology and Clinical Significance Noroviruses are considered the most common cause of outbreaks of non-bacterial gastroenteritis worldwide, are the leading cause of foodborne illness in the United States (58%), and account for 26% of hospitalizations and 10% of deaths associated with food consumption. Salad ingredients, fruit, and oysters are the most implicated in norovirus outbreaks. Aside from food and water, Noroviruses can also be transmitted by person to person contact and contact with environmental surfaces. The rapid spread of secondary infections occurs in areas where a large population is enclosed within a static environment, such as cruise ships, military bases, and institutions. Symptoms typically last for 24 to 48 hours, but can persist up to 96 hours in the immunocompromised. Pathogenesis, Immunity, Treatment and Prevention Norovirus is highly infectious due to low infecting dose, high excretion level (105 to 107 copies/mg stool), and continual shedding after clinical recovery (>1 month). The norovirus genome undergoes frequent change due to mutation and recombination, which increases its prevalence. Studies suggest that acquired immunity only last 6 months after infection. Gastroenteritis, an inflammation of the stomach and small and large intestines, is caused by norovirus infection.
    [Show full text]
  • Viruses in Transplantation - Not Always Enemies
    Viruses in transplantation - not always enemies Virome and transplantation ECCMID 2018 - Madrid Prof. Laurent Kaiser Head Division of Infectious Diseases Laboratory of Virology Geneva Center for Emerging Viral Diseases University Hospital of Geneva ESCMID eLibrary © by author Conflict of interest None ESCMID eLibrary © by author The human virome: definition? Repertoire of viruses found on the surface of/inside any body fluid/tissue • Eukaryotic DNA and RNA viruses • Prokaryotic DNA and RNA viruses (phages) 25 • The “main” viral community (up to 10 bacteriophages in humans) Haynes M. 2011, Metagenomic of the human body • Endogenous viral elements integrated into host chromosomes (8% of the human genome) • NGS is shaping the definition Rascovan N et al. Annu Rev Microbiol 2016;70:125-41 Popgeorgiev N et al. Intervirology 2013;56:395-412 Norman JM et al. Cell 2015;160:447-60 ESCMID eLibraryFoxman EF et al. Nat Rev Microbiol 2011;9:254-64 © by author Viruses routinely known to cause diseases (non exhaustive) Upper resp./oropharyngeal HSV 1 Influenza CNS Mumps virus Rhinovirus JC virus RSV Eye Herpes viruses Parainfluenza HSV Measles Coronavirus Adenovirus LCM virus Cytomegalovirus Flaviviruses Rabies HHV6 Poliovirus Heart Lower respiratory HTLV-1 Coxsackie B virus Rhinoviruses Parainfluenza virus HIV Coronaviruses Respiratory syncytial virus Parainfluenza virus Adenovirus Respiratory syncytial virus Coronaviruses Gastro-intestinal Influenza virus type A and B Human Bocavirus 1 Adenovirus Hepatitis virus type A, B, C, D, E Those that cause
    [Show full text]
  • Summary of Antimicrobial Activity
    SUMMARY OF ANTIMICROBIAL ACTIVITY 3x RENEGADE DAILY ONE-STEP DISINFECTANT Description 3x RENEGADE DAILY Disinfectant & Detergent is a broad spectrum, hard surface disinfectant. When used as directed, this product will deliver effective biocidal action against bacteria, fungi, and viruses. This formulation is a blend of a premium active ingredients and inerts: surfactants, chelates, and water. Biocidal performance is attained when this product is properly diluted at 1/2 oz. per gallon or 1:256 (1 oz. per gallon or 1:128 for Norovirus). 3x RENEGADE DAILY can be used to disinfect a wide variety of hard surfaces such as floors, walls, toilets, sinks, and countertops in hospitals, households, and institutions. Regulatory Summary Physical Properties EPA Registration No. 6836-349- pH of Concentrate 12.0 – 13.5 Flash Point (PMCC) >200 F 12120 USDA Authorization None Specific Gravity @ 0.98 – 1.05 g/mL % Quat (mol. wt.342.0) 22.24 25°C California Status Pounds per gallon @ 8.42 – 8.51 % Volatile 93.5-94.5 25°C Canadian PCP# None Canadian Din # None Summary of Antimicrobial Test Results 3x RENEGADE DAILY is a "One-Step" Hospital Disinfectant, Virucide, Fungicide, Mildewstat, Sanitizer and Cleaner. Listed in the following pages is a summary of Antimicrobial Claims and a review of test results. Claim: Contact time: Organic Soil: Water Conditions: Disinfectant Varies 5% 250ppm as CaCO3 Test Method: AOAC Germicidal Spray Test Organism Contact Dilution Time (Min) 868 ppm (1/2oz. per Acinetobacter baumannii 3 Gal) Bordetella bronchiseptica 3 868 ppm Bordetella pertussis 3 868 ppm Campylobacter jejuni 3 868 ppm Enterobacter aerogenes 3 1736 PPM (1 oz per Gal) Enterococcus faecalis 3 868 ppm Enterococcus faecalis - Vancomycin resistant [VRE] 3 868 ppm Escherichia coli 3 868 ppm Escherichia coli [O157:H7] 3 868 ppm Escherichia coli ESBL – Extended spectrum beta- 868 ppm 10 lactamase containing E.
    [Show full text]
  • Scwds Briefs
    SCWDS BRIEFS A Quarterly Newsletter from the Southeastern Cooperative Wildlife Disease Study College of Veterinary Medicine The University of Georgia Phone (706) 542 - 1741 Athens, Georgia 30602 FAX (706) 542-5865 Volume 36 April 2020 Number 1 Working Together: The 40th Anniversary of limited HD reports probably relate to enzootic the National Hemorrhagic Disease Survey stability; on the northern edge, the low frequency of reports is likely driven by limited EHDV and BTV In the last issue of the SCWDS BRIEFS, hemorrhagic transmission due to either the absence of vectors or disease (HD) report data from Indiana, Ohio, environmental conditions that reduce vector numbers Kentucky, and West Virginia were highlighted to or their ability to transmit these viruses. Within these demonstrate how these long-term data can help states, east-west gradients in HD reporting also are detect and map the northern expansion of HD over evident. The factors that drive this within-state time. In addition to providing a means to detect variation are not well understood and possibly relate temporal changes in HD patterns, this long-term data to habitat gradients and complex set provides a window to better understand spatial vector/host/environmental interactions that are patterns and risks within areas where HD has unique to each individual state. historically occurred. In part two of this four-part series, we will explore HD patterns in another area – the Great Plains, where HD is commonly reported and large-scale outbreaks occasionally occur. These states were included in the survey in 1982, and thanks to their continued support, this data set now spans 38 years.
    [Show full text]
  • Norovirus in Healthcare Facilities Fact Sheet Released December 21, 2006
    Norovirus in Healthcare Facilities Fact Sheet Released December 21, 2006 Diagnosis of norovirus infection Diagnosis of norovirus infection relies on the detection of viral RNA in the stools of affected persons, by use of reverse transcription- polymerase chain reaction (RT-PCR) assays. This technology is available at CDC and most state public health laboratories and should be considered in the event of outbreaks of gastroenteritis in healthcare facilities. Identification of the virus can be best made from stool specimens taken within 48 to 72 hours after onset of symptoms, although good results can be obtained by using RTPCR on General Information samples taken as long as 7 days after symptom onset. Other methods of diagnosis, usually only available in research settings, include Virology electron microscopy and serologic assays for a rise in titer in paired Noroviruses (genus Norovirus, family Caliciviridae) are a sera collected at least three weeks apart. Commercial enzyme-linked group of related, single-stranded RNA, non-enveloped immunoassays are available but are of relatively low sensitivity, so viruses that cause acute gastroenteritis in humans. their use is limited to diagnosis of the etiology of outbreaks. Because Norovirus was recently approved as the official genus name of the limited availability of timely and routine laboratory diagnostic for the group of viruses provisionally described as “Norwalk- methods, a clinical diagnosis of norovirus infection is often used, like viruses” (NLV). Currently, human noroviruses belong to especially when other agents of gastroentertis have been ruled out. one of three norovirus genogroups (GI, GII, or GIV), each of which is further divided into >25 genetic clusters.
    [Show full text]
  • Glycosphingolipids As Receptors for Non-Enveloped Viruses
    Viruses 2010, 2, 1011-1049; doi:10.3390/v2041011 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Glycosphingolipids as Receptors for Non-Enveloped Viruses Stefan Taube †, Mengxi Jiang † and Christiane E. Wobus * Department of Microbiology and Immunology, University of Michigan Medical School, 5622 Medical Sciences Bldg. II, 1150 West Medical Center Dr., Ann Arbor, MI 48109, USA; E-Mails: [email protected] (S.T.); [email protected] (M.J.) † These authors contributed equally to the work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-734-647-9599; Fax: +1-734-764-3562. Received: 2 March 2010; in revised form: 09 April 2010 / Accepted: 13 April 2010 / Published: 15 April 2010 Abstract: Glycosphingolipids are ubiquitous molecules composed of a lipid and a carbohydrate moiety. Their main functions are as antigen/toxin receptors, in cell adhesion/recognition processes, or initiation/modulation of signal transduction pathways. Microbes take advantage of the different carbohydrate structures displayed on a specific cell surface for attachment during infection. For some viruses, such as the polyomaviruses, binding to gangliosides determines the internalization pathway into cells. For others, the interaction between microbe and carbohydrate can be a critical determinant for host susceptibility. In this review, we summarize the role of glycosphingolipids as receptors for members of the non-enveloped calici-, rota-, polyoma- and parvovirus families. Keywords: non-enveloped virus; glycosphingolipid; receptor; calicivirus; rotavirus; polyomavirus; parvovirus 1. Introduction Viruses come in many different flavors and are often broadly classified based on their nucleic acid content (DNA versus RNA virus), capsid symmetry (icosahedral, helical, or complex), and the presence or absence of a lipid envelope (enveloped versus non-enveloped).
    [Show full text]
  • Chapter 6 - Virology Viruses in Action!!
    Chapter 6 - Virology Viruses in Action!! • Topics – Structure – Classification – Multiplication – Cultivation and replication – Nonviral infectious agent – Teratogenic/Oncogenic - Viruses have a host range. That is, viruses infect specific cells or tissues of specific hosts, or specific bacteria, Human or specific plants. Rhinovirus Common - Viral specificity refers to the specific Cold kinds of cells a virus can infect. It is regulated by the specificities of attachment, penetration and replication of the virus Properties of viruses A virion is an infectious virus particle - not all virus Viruses are not cells, do not have nuclei or particles are infectious mitochondria or ribosomes or other cellular Viruses are composed of a nucleic acid, RNA or DNA components. - never both . Viruses replicate or multiply. Viruses do not grow. All viruses have a protein coat or shell that surrounds Viruses replicate or multiply only within living cells. and protects the nucleic acid core. Viruses are obligate intracellular parasites . Some viruses have a lipid envelope or membrane surrounding a nucleocapsid core. The source of the The term virus was coined by Pasteur, and is from envelope is from the membranes of the host cell. the Latin word for poison. Some viruses package enzymes - e.g. RNA- Components of viruses - dependent-RNA polymerase or other enzymes - some do not package enzymes 1 Size comparison of viruses - how big are they? Structure • Size and morphology • Capsid • Envelope • Complex • Nucleic acid Mycoplasma? There are two major structures
    [Show full text]
  • Structure Unveils Relationships Between RNA Virus Polymerases
    viruses Article Structure Unveils Relationships between RNA Virus Polymerases Heli A. M. Mönttinen † , Janne J. Ravantti * and Minna M. Poranen * Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikki Biocenter 1, P.O. Box 56 (Viikinkaari 9), 00014 Helsinki, Finland; heli.monttinen@helsinki.fi * Correspondence: janne.ravantti@helsinki.fi (J.J.R.); minna.poranen@helsinki.fi (M.M.P.); Tel.: +358-2941-59110 (M.M.P.) † Present address: Institute of Biotechnology, Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Viikki Biocenter 2, P.O. Box 56 (Viikinkaari 5), 00014 Helsinki, Finland. Abstract: RNA viruses are the fastest evolving known biological entities. Consequently, the sequence similarity between homologous viral proteins disappears quickly, limiting the usability of traditional sequence-based phylogenetic methods in the reconstruction of relationships and evolutionary history among RNA viruses. Protein structures, however, typically evolve more slowly than sequences, and structural similarity can still be evident, when no sequence similarity can be detected. Here, we used an automated structural comparison method, homologous structure finder, for comprehensive comparisons of viral RNA-dependent RNA polymerases (RdRps). We identified a common structural core of 231 residues for all the structurally characterized viral RdRps, covering segmented and non-segmented negative-sense, positive-sense, and double-stranded RNA viruses infecting both prokaryotic and eukaryotic hosts. The grouping and branching of the viral RdRps in the structure- based phylogenetic tree follow their functional differentiation. The RdRps using protein primer, RNA primer, or self-priming mechanisms have evolved independently of each other, and the RdRps cluster into two large branches based on the used transcription mechanism.
    [Show full text]
  • RNA Sequence of Astrovirus: Distinctive Genomic Organization and a Putative Retrovirus-Like Ribosomal Frameshifting Signal That Directs the Viral Replicase Synthesis
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 10539-10543, November 1993 Microbiology RNA sequence of astrovirus: Distinctive genomic organization and a putative retrovirus-like ribosomal frameshifting signal that directs the viral replicase synthesis BAOMING JIANG*t, STEPHAN S. MONROE*, EUGENE V. KOONINt, SARAH E. STINE*, AND ROGER I. GLASS* *Viral Gastroenteritis Section, Centers for Disease Control and Prevention, Atlanta, GA 30333; and tNational Center for Biotechnology Information, National Institutes of Health, Bethesda, MD 20894 Communicated by Bernard Fields, July 27, 1993 ABSTRACT The genomic RNA of human astrovirus was In the present study, we have sequenced and analyzed the sequenced and found to contain 6797 nt organized into three entire genomic RNA of H-Ast2§ and compared the sequence open reading frames (la, lb, and 2). A potential ribosomal and genomic structure with those of other positive-strand frameshift site identified in the overlap region of open reading RNA viruses. The results highlight the specific genomic frames la and lb consists ofa "shifty" heptanucleotide and an organization of astroviruses and support their classification RNA stem-loop structure that closely resemble those at the in a separate virus family. gag-pro junction of some retroviruses. This translation frame- shift may result in the suppression of in-frame amber termi- nation at the end of open reading frame la and the synthesis of MATERIALS AND METHODS a nonstructural, fusion polyprotein that contains the putative Cells and Virus. LLCMK2 cells (ATCC CCL 7.1) were protease and RNA-dependent RNA polymerase. Comparative propagated in Earle's minimal essential medium (MEM) sequence analysis indicated that the protease and polymerase of supplemented with antibiotics-and 10% fetal bovine serum.
    [Show full text]
  • Reverse Genetics of Rotavirus Ulrich Desselbergera,1
    COMMENTARY COMMENTARY Reverse genetics of rotavirus Ulrich Desselbergera,1 The genetics of viruses are determined by mutations clarify structure/function relationships of viral genes of their nucleic acid. Mutations can occur spontane- and their protein products and also elucidate complex ously or be produced by physical or chemical means: phenotypes, such as host restriction, pathogenicity, for example, the application of different temperatures and immunogenicity. or mutagens (such as hydroxylamine, nitrous acid, or Kanai et al. (1) have now developed a reverse ge- alkylating agents) that alter the nucleic acid. The clas- netics system for rotaviruses (RVs), which are a major sic way to study virus mutants is to identify a change in cause of acute gastroenteritis in infants and young chil- phenotype compared with the wild-type and to corre- dren and in many mammalian and avian species. World- late this with the mutant genotype (“forward genet- wide RV-associated disease still leads to the death of ics”). Mutants can be studied by complementation, over 200,000 children of <5 y of age per annum (2) recombination, or reassortment analyses. These ap- and thus represents a major public health problem. proaches, although very useful, are cumbersome and The work by Kanai et al. (1) is the most recent ad- prone to problems by often finding several mutations dition to a long list of plasmid-only–based reverse ge- in a genome that are difficult to correlate with a change netics systems of RNA viruses, a selection of which is in phenotype. With the availability of the nucleotide presented in Table 1 (3–13).
    [Show full text]
  • HEPATITIS E the Leading Cause of Acute Viral Hepatitis in the World
    HEPATITIS E The Leading Cause of Acute Viral Hepatitis in the World The hepatitis E virus is the leading cause of acute (short-lived) viral hepatitis in the world, and occurs primarily in Africa, Central Asia and Mexico. It accounts for half of all acute hepatitis infection outbreaks in children and adults in areas where it is endemic. Worldwide, hepatitis E virus (HEV) infection is more prevalent than hepatitis A virus infection. Researchers suspect that as many as 20 percent of the world’s population has been infected by the hepatitis E virus. The virus is most common in people between the ages of 15 to 40. In young children, HEV infection often has no symptoms. In adult populations, hepatitis E can wreak havoc. Since the early 1950s, there have been water-borne hepatitis E epidemics reported in New Delhi, India, the former Soviet Union, Nepal, Myanmar (Burma), Algeria, Pakistan, Cote d’Ivoire (Ivory Coast), Bor- neo and in refugee camps in Sudan and Somalia. The virus is transmitted through food or water contaminated by the feces of infected people, but unlike the hepatitis A virus, it is not spread through close person-to-person contact. For some reason that eludes Like hepatitis A, an HEV infection never develops medical researchers, between into a chronic or long-term illness. However, in 15 to 25 percent of pregnant adults, hepatitis E is more severe than hepatitis A, women infected with hepatitis E die, according to the National with death rates reaching between 1 and 2 percent. Centers for Disease Control In contrast, adult death rates from hepatitis A are and Prevention (CDC).
    [Show full text]